Suchergebnisse - "McEwen, Robert"

PubPharm (40)

1

Biomarkers and methods of treating cancer

enthalten in: Europäisches Patentamt | 2023

von AVIVAR VALDERAS ALVARO | CRUZALEGUI FRANCISCO HUMBERTO | HUDSON KEVIN | +1

2

AUDIO-BASED INTERACTIVE SIMULTANEOUS EXERCISE AND COGNITIVE CONTROL TRAINING FOR IMPROVING COGNITIVE NETWORKS SUBSERVING NEUROPSYCHIATRIC AND NEUROCOGNITIVE CONDITIONS

enthalten in: Europäisches Patentamt | 2023

von MCEWEN SARAH | MCEWEN ROBERT

3

AKT-mTORC1 reactivation is the dominant resistance driver for PI3Kβ/AKT inhibitors in PTEN-null breast cancer and can be overcome by combining with Mcl-1 inhibitors

enthalten in: Oncogene | 2022

von Dunn, S. | Eberlein, C. | Yu, J. | +18

4

Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von Lipsyc-Sharf, M. | de Bruin, E. | Santos, K. | +15

CommentIn: J Clin Oncol. 2022 Aug 1;40(22):2395-2397. - PMID 35658519

5

An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer

enthalten in: Nature medicine | 2021

von Powles, T. | Carroll, D. | Chowdhury, S. | +21

CommentIn: Nat Med. 2021 May;27(5):761-763. - PMID 33941920

6

Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer

enthalten in: NPJ breast cancer | 2021

von Smyth, L. | Batist, G. | Meric-Bernstam, F. | +24

7

Capivasertib, an AKT Kinase Inhibitor, as Monotherapy or in Combination with Fulvestrant in Patients with AKT1 E17K-Mutant, ER-Positive Metastatic Breast Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Smyth, L. | Tamura, K. | Oliveira, M. | +25

8

Adenosine Signaling Is Prognostic for Cancer Outcome and Has Predictive Utility for Immunotherapeutic Response

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Sidders, B. | Zhang, P. | Goodwin, K. | +16

9

Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer : The PAKT Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2020

von Schmid, P. | Abraham, J. | Chan, S. | +26

CommentIn: Nat Rev Clin Oncol. 2020 Mar;17(3):135. - PMID 31900440

10

STK11 (LKB1) mutations in metastatic NSCLC : Prognostic value in the real world

enthalten in: PloS one | 2020

von Shire, N. | Klein, A. | Golozar, A. | +6